Literature DB >> 17612680

Troponin T elevation and prognosis after multivessel compared with single-vessel elective percutaneous coronary intervention.

M B Nienhuis1, J P Ottervanger, J-H E Dambrink, L D Dikkeschei, H Suryapranata, A W J van 't Hof, J C A Hoorntje, M J de Boer, A T M Gosselink, F Zijlstra.   

Abstract

BACKGROUND.: Although techniques for percutaneous coronary intervention (PCI) have improved, patients with PCI of more vessels may still have an increased risk. We performed a prospective observational study evaluating the differences between multivessel and single-vessel procedures according to postprocedural troponin T (TnT) elevation and events during follow-up. METHODS.: The study included 713 patients without elevated TnT (<0.05 ng/ml) before PCI. Primary endpoint was the combined endpoint of death, myocardial infarction, stroke, repeat coronary angiography and readmission for anginal symptoms during the mean follow-up of 10.9 months. RESULTS.: TnT after PCI was elevated in 150 patients (21%) and was significantly associated with an increased incidence of the primary endpoint (RR 1.55, 95% CI 1.01 to 2.38). PCI of more than one vessel was performed in 146 patients (20%). These patients more often had increased TnT levels after the procedure (31.5 vs. 18.3%, p=0.001) and an increased incidence of the primary endpoint during follow-up (28 vs. 19%, p=0.01). After multivariable analysis, multivessel PCI was a statistically significant predictor of postprocedural TnT increase (OR 1.90, 95% CI 1.17 to 3.06). Multivessel PCI was also associated with an increased risk of the primary endpoint (OR 1.73, 95% CI 1.18 to 2.52), but after adjusting for multivessel disease this association was not statistically significant (OR 1.42, 95% CI 0.92 to 2.19). CONCLUSION.: Elective PCI of more vessels in one session is, in comparison with single-vessel PCI, more often associated with postprocedural troponin T rise and a (nonsignificantly) higher incidence of cardiac events during follow-up. Whether staged PCI is associated with less morbidity has to be assessed. (Neth Heart J 2007;15:178-83.).

Entities:  

Year:  2007        PMID: 17612680      PMCID: PMC1877967          DOI: 10.1007/BF03085977

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  29 in total

1.  Staged versus one-step approach for multivessel percutaneous coronary interventions.

Authors:  Eugenia Nikolsky; Majdi Halabi; Ariel Roguin; Alexander Zdorovyak; Luis Gruberg; Jamal Hir; Ehud Grenadier; Monther Boulos; Walter Markiewicz; Shai Linn; Rafael Beyar
Journal:  Am Heart J       Date:  2002-06       Impact factor: 4.749

2.  Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions.

Authors:  Madhu K Natarajan; Catherine Kreatsoulas; James L Velianou; Shamir R Mehta; Dan Pericak; David M Goodhart
Journal:  Am J Cardiol       Date:  2004-03-15       Impact factor: 2.778

3.  Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease.

Authors:  Alexandre Berger; Kees-Joost Botman; Philip A MacCarthy; William Wijns; Jozef Bartunek; Guy R Heyndrickx; Nico H J Pijls; Bernard De Bruyne
Journal:  J Am Coll Cardiol       Date:  2005-08-02       Impact factor: 24.094

4.  ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention).

Authors:  Sidney C Smith; Ted E Feldman; John W Hirshfeld; Alice K Jacobs; Morton J Kern; Spencer B King; Douglass A Morrison; William W O'Neill; Hartzell V Schaff; Patrick L Whitlow; David O Williams; Elliott M Antman; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2006-01-03       Impact factor: 29.690

5.  Outcome of multivessel coronary intervention in the contemporary percutaneous revascularization era.

Authors:  Mehdi H Shishehbor; Eric J Topol; Debabrata Mukherjee; Tingfei Hu; David J Cohen; Gregg W Stone; Rick McClure; Marco Roffi; David J Moliterno
Journal:  Am J Cardiol       Date:  2006-04-06       Impact factor: 2.778

6.  Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.

Authors:  M J Lenzen; E Boersma; M E Bertrand; W Maier; C Moris; F Piscione; U Sechtem; E Stahle; P Widimsky; P de Jaegere; W J M Scholte op Reimer; N Mercado; W Wijns
Journal:  Eur Heart J       Date:  2005-03-31       Impact factor: 29.983

7.  Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque.

Authors:  Diana Bonderman; Alexander Teml; Johannes Jakowitsch; Christopher Adlbrecht; Mariann Gyöngyösi; Wolfgang Sperker; Harald Lass; Wilhelm Mosgoeller; Dietmar H Glogar; Peter Probst; Gerald Maurer; Yale Nemerson; Irene M Lang
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

Review 8.  Prognostic value of troponin after elective percutaneous coronary intervention: A meta-analysis.

Authors:  Mark B Nienhuis; Jan Paul Ottervanger; Henk J G Bilo; Bert D Dikkeschei; Felix Zijlstra
Journal:  Catheter Cardiovasc Interv       Date:  2008-02-15       Impact factor: 2.692

9.  Evaluation and risk stratification of acute coronary syndromes using a low cut-off level of cardiac troponin T, combined with CK-MB mass determination.

Authors:  B Charles Solymoss; Martial G Bourassa; Annik Fortier; Pierre Théroux
Journal:  Clin Biochem       Date:  2004-04       Impact factor: 3.281

10.  Troponin T elevation and prognosis after multivessel compared with single-vessel elective percutaneous coronary intervention.

Authors:  M B Nienhuis; J P Ottervanger; J-H E Dambrink; L D Dikkeschei; H Suryapranata; A W J van 't Hof; J C A Hoorntje; M J de Boer; A T M Gosselink; F Zijlstra
Journal:  Neth Heart J       Date:  2007-05       Impact factor: 2.380

View more
  2 in total

1.  Multivessel percutaneous coronary intervention in patients with stable angina: a common approach? Lessons learned from the EHS PCI registry.

Authors:  Timm Bauer; Helge Möllmann; Uwe Zeymer; Matthias Hochadel; Holger Nef; Franz Weidinger; Ralf Zahn; Christian W Hamm; Jean Marco; Anselm K Gitt
Journal:  Heart Vessels       Date:  2011-11-09       Impact factor: 2.037

2.  Troponin T elevation and prognosis after multivessel compared with single-vessel elective percutaneous coronary intervention.

Authors:  M B Nienhuis; J P Ottervanger; J-H E Dambrink; L D Dikkeschei; H Suryapranata; A W J van 't Hof; J C A Hoorntje; M J de Boer; A T M Gosselink; F Zijlstra
Journal:  Neth Heart J       Date:  2007-05       Impact factor: 2.380

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.